August 03, 2017
Caradigm Adds Insignia Health’s Patient Activation Measure Survey into Its Care Management Solution
Helps Providers Improve Patient Care, Financial Strategies & Overall Population Health
Caradigm, a GE Healthcare company and leader in enterprise population health, today announced the integration of Insignia Health’s Patient Activation Measure® (PAM®) self-management survey into Caradigm’s Care Management solution to help large integrated delivery networks, academic medical centers, government facilities and community hospitals gain better results in clinical outcomes while reducing costs.
By using the integrated solution, customers will be better able to:
- Accurately and quickly predict individuals at risk for adverse health outcomes, chronic conditions and costly utilization
- Reduce healthcare costs
- Improve patient care quality, health behaviors and outcomes
- Bolster patient satisfaction and retention
- Increase operational efficiencies
- Achieve quality and performance metrics (e.g., STAR ratings, CAHPS scores, URAC and NCQA standards, HEDIS measures, MACRA/MIPS requirements)
PAM measures the ability of individuals to self-manage their health and healthcare by segmenting respondents into one of four activation levels along a 100-point scale. These results provide insight into behaviors, characteristics, attitudes and motivators for health self-management, and can be used as a key indicator in clinical practice and health coaching. PAM is supported by over a decade of health research and more than 350 peer-reviewed published studies. In 2016, PAM was endorsed by the National Quality Forum (NQF) as a person and family-centered care measure. State Medicaid programs in a number of states mandate use of PAM, including New York and Washington, and PAM is accepted as a MIPS measure for Medicare reimbursement under MACRA.
“Caradigm is excited to add a patient activation tool to our enterprise population health portfolio,” said Caradigm CEO Neal Singh. “PAM offers measurable results and increases our ability to help customers predict costs and outcomes, improve care, reduce costs and exceed healthcare benchmarks.”
Research consistently shows that as activation increases, patients become more adherent to medication and treatment plans, less likely to utilize expensive emergency and hospital services, and more satisfied with the care they receive. The predictive power of PAM helps healthcare professionals better allocate their time and resources.
“With Caradigm operating in more than 1,500 hospitals worldwide and connecting to more than 175 million patients, we are able to extend activation benefits to more providers and patients,” said Craig Swanson, President of Insignia Health. “When care programs are tailored to activation levels, proven measurable results are realized including improved overall healthcare and cost reductions,” he added.
Caradigm, a GE Healthcare company, is an award-winning population health company dedicated to improving patient care, advancing the health of populations and reducing healthcare costs. Its enterprise software portfolio encompasses all capabilities critical to delivering effective population health management, including data control; healthcare analytics; and care coordination and engagement.
Caradigm’s 200+ customers include Greenville Health System, Billings Clinic and Virtua and other large integrated delivery networks, ACOs, academic medical centers, government facilities and community hospitals. Caradigm solutions are operating in more than 1,500 hospitals worldwide, connect to over 500 customer systems and to data for more than 175 million patients. In addition, its identity and access management solutions are employed daily by over 1.2 million users, ensuring patient privacy and security by safeguarding access to patient health information. Based in Bellevue, WA, Caradigm has been recognized as one of Healthcare Informatics’ Top 100 vendors. To learn more, go to www.caradigm.com.
Insignia Health is the gold standard provider of patient activation solutions that pinpoint population health risk, improve health outcomes, reduce healthcare costs and increase patient/member satisfaction. The Patient Activation Measure® (PAM®) survey is a predictive powerhouse backed by over a decade of health activation research and insight gained from supporting hospitals, health systems, health plans, life science firms and government agencies around the globe. Our products and services help organizations exceed performance objectives by measuring activation and tailoring care programs to specific activation levels. We strive to lessen disease, illness burden and premature deaths around the world. Insignia Health is headquartered in Portland, Oregon. Visit www.insigniahealth.com, email email@example.com or follow us on Facebook and Twitter.